Ann: Prescient Therapeutics Launches Share Purchase Plan, page-5

While a cash raise isn't usually news that makes me happy... this one does.

Why?

Because it gives opportunity to increase holdings before the big boys are here to play AND it gives the PTX board the funds to go harder with the science that looks to have such impressive disruptive and scalable application.

Unlike others on these forums, I've been concerned about PTX and cash. Although PTX decent $ in the bank, the pending Omnicar trials will add to overheads considerably and the board has an ethical responsibility to get this science to market ASAP, without running out of cash.

Now we all need to go on a spare cash hunt and collect our share of this beauty.

Bring on the science.

Gav